FDA Cancels Cipla’s Pune Unit Drug Sale Licences
The Food and Drug Administration has cancelled the drug sale licences for Cipla Pharma & Life Sciences' Pune Carry and Forwarding unit, citing 'irregularities' and alleged violations involving Reactin Plus. Cipla has promptly contested this…
Read More